Atlas Trials

Neurobiological Effects of Psilocybin in Treatment Resistant Bipolar Depression

Clinical trial NCT06506019 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06506019
Sponsor
University Health Network, Toronto
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Bipolar Depression
Start date
2024-10-09
Primary completion
2026-09-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.